The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this …

Objective To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19)
who died. Design Retrospective case series. Setting Tongji Hospital in Wuhan, …

Background: Although many studies have demonstrated the epidemiologic characteristics of
SARS-CoV-2 disease (COVID-19), details of pathologic changes in the lung are still lacking…

Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel
betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, …

Background In December 2019, the coronavirus disease 2019 (COVID-19) outbreak occurred
in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID…

Background No specific antiviral drug has been proven effective for treatment of patients
with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside …

Background Although exposure to cigarette smoking and air pollution is common, the current
prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the Chinese …

Background Accumulating evidence proposed Janus-associated kinase (JAK) inhibitors as
therapeutic targets warranting rapid investigation. Objective This study evaluated the efficacy …

In their Comment about the use of corticosteroids to treat 2019 novel coronavirus (2019-nCoV)
lung injury, Clark Russell and colleagues1 summarise the available clinical evidence on …

Background Asthma is a common chronic airway disease worldwide. Despite its large
population size, China has had no comprehensive study of the national prevalence, risk factors, …